Homocysteine Lowering and Cognition in CKD: The Veterans Affairs Homocysteine Study
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background Individuals with advanced chronic kidney disease (CKD) and end stage renal disease (ESRD) have high total plasma homocysteine (tHcy) levels, which may be a risk factor for cognitive impairment. Whether treatment with high dose B-vitamins to reduce high tHcy levels improves cognition in persons with kidney disease is unknown. Study Design Randomized controlled trial. Setting & Participants A substudy of 659 patients (mean age 67.3 ± 11.7 years) who participated in a randomized, double-blind, clinical trial, 5 years in duration, conducted in 36 US Department of Veterans Affairs medical centers, of the effect on all-cause mortality of vitamin-induced lowering of plasma tHcy. 236 (35.8%) were treated by dialysis (ESRD) and 423 (64.2%) had a Cockcroft-Gault estimated creatinine clearance ≤ 30 ml/min (advanced CKD). All had high tHcy levels (≥15 μmol/L) at baseline. Cognitive assessments began during the follow up period of the main trial, 3 years after treatment began; participants were subsequently retested one year later to assess cognitive change. Intervention Daily high dose B-vitamin capsule (40 mg of folic acid, 100 mg of vitamin B6, and 2 mg of vitamin B12) or placebo. Outcomes Cognitive function at initial assessment and one year later. Measurements The Telephone Interview of Cognitive Status – modified, supplemented with attention, working memory and executive function tests. Results Initial cognitive function was impaired in approximately 19% of patients, regardless of treatment assignment (vitamin or placebo) or kidney disease status (advanced CKD or ESRD). Treatment reduced tHcy levels by 26.7%. Unadjusted and adjusted analyses showed that treatment did not improve initial cognitive outcomes or affect subsequent cognitive status one year later. Limitations Cognitive assessments began after treatment was initiated; cognitive assessment was limited. Conclusion Treatment with high daily doses of B-vitamins, which reduced tHcy levels, did not affect cognitive outcomes in patients with advanced CKD and ESRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758
Cognitive impairment in hemodialysis patients is common
Murray, A. M., Tupper, D. E., Knopman, D. S., Gilbertson, D. T., Pederson, S. L., Li, S., Smith, G. E., Hochhalter, A. K., Collins, A. J., & Kane, R. L. (2006) · Neurology · doi:10.1212/01.wnl.0000225182.15532.40 · Cited by 712
Kurella Tamura, M., Wadley, V., Yaffe, K., McClure, L. A., Howard, G., Go, R., Allman, R. M., Warnock, D. G., & McClellan, W. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.05.004 · Cited by 388
Haan, M. N., Miller, J. W., Aiello, A. E., Whitmer, R. A., Jagust, W. J., Mungas, D. M., Allen, L. H., & Green, R. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.511 · Cited by 260
Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important
Elias, M. F., Sullivan, L. M., D'Agostino, R. B., Elias, P. K., Jacques, P. F., Selhub, J., Seshadri, S., Au, R., Beiser, A., & Wolf, P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi259 · Cited by 136
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
Kang, J. H., Cook, N., Manson, J., Buring, J. E., Albert, C. M., & Grodstein, F. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26404 · Cited by 114
Cited by
Mechanisms of cognitive dysfunction in CKD
Viggiano, D., Wagner, C. A., Martino, G., Nedergaard, M., Zoccali, C., Unwin, R., & Capasso, G. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0266-9 · Cited by 392
Chronic Kidney Disease and Cognitive Impairment: A Systematic Review and Meta-Analysis
Etgen, T., Chonchol, M., Förstl, H., & Sander, D. (2012) · American Journal of Nephrology · doi:10.1159/000338135 · Cited by 359
Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies
Kurella Tamura, M., & Yaffe, K. (2011) · Kidney International · doi:10.1038/ki.2010.336 · Cited by 331
Cognitive impairment and vitamin B12: a review
Moore, E., Mander, A., Ames, D., Carne, R., Sanders, K., & Watters, D. (2012) · International Psychogeriatrics · doi:10.1017/s1041610211002511 · Cited by 260
Metadata
- Authors
- Brady, C. B., Gaziano, J. M., Cxypoliski, R. A., Guarino, P. D., Kaufman, J. S., Warren, S. R., Hartigan, P., Goldfarb, D. S., & Jamison, R. L.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 54
- Issue
- 3
- Pages
- 440-449
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2087146407
- Cited by
- 75
- References
- 8
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.